The company and other insurers have faced backlash from patients who say they were denied necessary care and providers say ...

Health insurer stocks fell early Thursday after the Centers for Medicare and Medicaid Services (CMS) said it would expand ...

The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...

Cigna’s Evernorth unit scored a deal with Eli Lilly and Novo Nordisk to make weight loss drugs more affordable for insured ...

The stock's fall snapped a five-day winning streak.

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...